Indigo Carmine: Clinical Trials

12 trials of Indigo Carmine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 4 unknown, 2 not yet recruiting, 1 recruiting. 5 Not applicable, 2 Phase 1, 2 Phase 2, 1 Early Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable5Unknown 4, Recruiting 1
Phase 12Completed 2
Phase 22Completed 2
Early Phase 11Completed 1
Phase 31Not yet recruiting 1
Phase 41Completed 1

Follow Indigo Carmine: new trials by email Literature Review of Indigo Carmine trials Research Report on Indigo Carmine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency in Pediatric Patients
Indigotindisulfonate sodium 0.8% injection - Ureter Injury
Phase 3Not yet recruitingProve pharm182026-12-012026-10-16
Evaluation of the Ileo-anal Pouch in FAP (ENDOPOL)
Chromoendoscopy (Indigo Carmine), Virtual Chromoendoscopy - Familial Adenomatous Polyposis (FAP), Pouches, Ileoanal
Not applicableRecruitingLondon North West Healthcare NHS Trust502026-07-092026-07-24
Hemodynamic and Respiratory Instability During Percutaneous Pulmonary Thrombectomy
Percutaneous Pulmonary Thrombectomy (FlowTriever), Percutaneous Pulmonary Thrombectomy (Indigo) - Pulmonary Embolism Acute
Not yet recruitingHospital Universitari Vall d'Hebron Research Institute1002026-04-102026-05-04
Chromoendoscopy in Inflammatory Bowel Disease
indigo-carmine 0.2% using a spray catheter, 0.03% using a foot pump - Colonoscopy
Not applicableUnknownThe Leeds Teaching Hospitals NHS Trust3002017-01-012019-06-18
Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease
Methylene Blue, FD&C Blue # 2, Phenazopyridine hydrochloride - Mild Cognitive Impairment, MCI
Phase 2CompletedThe University of Texas Health Science Center at San Antonio1172015-07-012024-09-19
Effects of USP Methylene Blue on Cognitive and fMRI Brain Activity
Methylene Blue (USP grade, 280mg oral), Placebo - Brain Activity
Early Phase 1CompletedThe University of Texas Health Science Center at San Antonio362013-08-012017-04-11
Chromoendoscopy of the Colon After Oral Administration of Indigo Carmine
Indigo Carmine - Inflammatory Bowel Diseases
Not applicableUnknownHillel Yaffe Medical Center102013-08-012013-08-02
Comparative Efficacy of Water & Indigo Carmine vs. Water or Air Method on Adenoma Detection Rate (ADR) - a Randomized Controlled Trial (RCT)
Indigo carmine, water (exchange) method, water (exchange) plus dye method - Colorectal Neoplasms
Phase 4CompletedVA Office of Research and Development4802013-05-162019-01-15
Panchromoendoscopy Using Oral Indigo Carmine Mixed With Polyethylene Glycol Prep
Chromoendoscopy (Indigo Carmine), Control - Colonic Polyps
Phase 1CompletedMayo Clinic212013-05-012015-03-03
Intra-operative Use of Indigo Carmine Dye for the Delineation of Ill Defined Tumor Borders Using Stereotactic Injection
Indigo carmine - Brain Tumors With Ill-defined Margins
Phase 1 / Phase 2CompletedWeill Medical College of Cornell University102012-04-012018-12-11
Chromoendoscopy for Dysplasia Detection in Chronic Inflammatory Bowel Disease
Colonoscopy with Indigo-Carmine chromoendoscopy, Conventional white-light colonoscopy - Ulcerative Colitis, Crohn's Colitis
Not applicableUnknownKarolinska University Hospital3042011-02-012019-03-06
Usefulness of Chromoendoscopy in Diagnosing Microscopic Colitis
Colonoscopy with Indigo-Carmine Chromoendoscopy - Chronic Diarrhoea, Lymphocytic Colitis
Not applicableUnknownKarolinska University Hospital1502009-06-012015-08-06

Conditions studied

Inflammatory Bowel Diseases (3)  ·  Adenomatous Polyposis Coli (1)  ·  Alzheimer Disease (1)  ·  Brain Neoplasms (1)  ·  Cognitive Dysfunction (1)  ·  Colitis, Collagenous (1)  ·  Colitis, Lymphocytic (1)  ·  Colitis, Microscopic (1)  ·  Colitis, Ulcerative (1)  ·  Colonic Polyps (1)  ·  Colorectal Neoplasms (1)  ·  Crohn Disease (1)  ·  Intestinal Diseases (1)  ·  Mental Fatigue (1)  ·  Neoplasms (1)

Sponsors

Karolinska University Hospital (2)  ·  The University of Texas Health Science Center at San Antonio (2)  ·  Hillel Yaffe Medical Center (1)  ·  Hospital Universitari Vall d'Hebron Research Institute (1)  ·  London North West Healthcare NHS Trust (1)  ·  Mayo Clinic (1)  ·  Prove pharm (1)  ·  The Leeds Teaching Hospitals NHS Trust (1)  ·  VA Office of Research and Development (1)  ·  Weill Medical College of Cornell University (1)

Countries

United States (5)  ·  Sweden (2)  ·  United Kingdom (2)  ·  Israel (1)  ·  Spain (1)

Top investigators

Peter T Schmidt, MD, PhD (2)  ·  Andre Latchford, MBBS PhD FRCP (1)  ·  Joseph W. Leung, MD (1)  ·  Lisa Schwartz (1)  ·  M Harrison, MD (1)  ·  Theodore Schwartz, MD (1)  ·  Timothy Q. Duong, Ph.D. (1)  ·  Vitaly Verzhbitsky, MD (1)

Results publications

PMID 22163081, PMID 32353535